Results 11 to 20 of about 302,208 (172)

Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame. [PDF]

open access: yesPLoS ONE, 2012
Oncolytic influenza A viruses with deleted NS1 gene (delNS1) replicate selectively in tumour cells with defective interferon response and/or activated Ras/Raf/MEK/ERK signalling pathway.
Marijke van Rikxoort   +7 more
doaj   +3 more sources

Oncolytic viruses for cancer immunotherapy [PDF]

open access: yesJournal of Hematology & Oncology, 2020
In this review, we discuss the use of oncolytic viruses in cancer immunotherapy treatments in general, with a particular focus on adenoviruses. These serve as a model to elucidate how versatile viruses are, and how they can be used to complement other ...
Otto Hemminki   +2 more
doaj   +2 more sources

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses

open access: yesViruses, 2016
The development of oncolytic viruses has led to an emerging new class of cancer therapeutics. Although the safety profile has been encouraging, the transition of oncolytic viruses to the clinical setting has been a slow process due to modifications ...
Ming Yuan   +3 more
doaj   +2 more sources

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy

open access: yesViruses, 2023
Oncolytic viruses (OVs) have emerged as one of the most promising cancer immunotherapy agents that selectively target and kill cancer cells while sparing normal cells. OVs are from diverse families of viruses and can possess either a DNA or an RNA genome.
Junior A. Enow   +2 more
doaj   +2 more sources

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy [PDF]

open access: yesBiologics: Targets & Therapy, 2018
Kenneth Lundstrom PanTherapeutics, Lutry, Switzerland Abstract: Oncolytic viruses have demonstrated selective replication and killing of tumor cells.
Lundstrom K
doaj   +2 more sources

Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses [PDF]

open access: yesFrontiers in Oncology, 2014
Oncolytic viruses kill cancer cells by direct lysis but also generate a significant anti-tumor immune response that allows for prolonged cancer control and in some cases cures.
Nicole E. Forbes   +5 more
doaj   +2 more sources

Development of a WNT-selective oncolytic adenovirus for imaging the therapy of colorectal cancers. [PDF]

open access: yes, 2008
PhDIntroduction: The concept of oncolytic adenoviruses has been validated in preclinical studies but clinical trials have demonstrated that the virus spread remains limited and the virus fails to infect all cancer cells in a tumour.
Peerlinck, Inge D. L.
core   +4 more sources

High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency

open access: yesMolecular Therapy: Oncolytics, 2019
Measles virus (MeV) is naturally cytolytic by extensive cell-to-cell fusion. Vaccine-derived MeV is toxic for cancer cells and is clinically tested as oncolytic virus.
Jan R.H. Hanauer   +3 more
doaj   +1 more source

Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?

open access: yesMolecular Therapy: Oncolytics, 2022
Oncolytic viruses are designed to specifically target cancer cells, sparing normal cells. Although numerous studies demonstrate the ability of oncolytic viruses to infect a wide range of non-tumor cells, the significance of this phenomenon for cancer ...
Victor A. Naumenko   +4 more
doaj   +1 more source

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic

open access: yesGlobal Challenges, 2023
Oncolytic viruses have found a good place in the treatment of cancer. Administering oncolytic viruses directly or by applying genetic changes can be effective in cancer treatment through the lysis of tumor cells and, in some cases, by inducing immune ...
Hai Zou, Xiao‐Zhou Mou, Biao Zhu
doaj   +1 more source

Home - About - Disclaimer - Privacy